Evidence map›Paper›PMID 28938026›Full record

ArticlePloS one2017

HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.

Elise Jackson, Cindy Xinyu Zhang, Zahra Kiani, Irene Lisovsky, Benjamin Tallon, Alexa Del Corpo, Louise Gilbert, Julie Bruneau, Réjean Thomas, Pierre Côté and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. HIV-Exposed Seronegative Female Sex Workers Show Different Cellular Immune Profiles Across the Menstrual Cycle.American journal of reproductive immunology (New York, N.Y. : 1989) · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Elise JacksonResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Cindy Xinyu ZhangResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Zahra KianiResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Irene LisovskyResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Benjamin TallonResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Alexa Del CorpoResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Louise GilbertResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Julie BruneauCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montreal, Quebec, Canada.
Réjean ThomasClinique Médicale l'Actuel, Montréal, Québec, Canada.
Pierre CôtéClinique Médicale du Quartier Latin, Montreal, Quebec, Canada.
Benoit TrottierClinique Médicale du Quartier Latin, Montreal, Quebec, Canada.
Roger LeBlancClinique OPUS, Montreal, Quebec, Canada.
Danielle RouleauDépartement de Microbiologie, Infectiologie et Immunologie, Montreal, Quebec, Canada.
Cécile TremblayCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montreal, Quebec, Canada.
Christos M TsoukasResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Jean-Pierre RoutyResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Xiaoyan NiResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Tsoarello MabangaResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.
Nicole F BernardResearch Institute of the McGill University Health Center (RI-MUHC), Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0001-5311-9409
Montreal Primary Infection Study Group
McGill University Health Centre · CACentre Hospitalier de l’Université de Montréal · CAClinique Paro Excellence · CAInstitute of Infection and Immunity · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we showed that Killer Immunoglobulin-like Receptor (KIR)3DS1 homozygotes (hmz) are more frequent in HIV exposed seronegative (HESN) than in recently HIV infected (HIV+) individuals. KIR3DS1 encodes an activating Natural Killer (NK) cell receptor (NKR). The link between KIR genotype and HIV outcomes likely arises from the function that NK cells acquire through expression of particular NKRs. An initial screen of 97 HESN and 123 HIV+ subjects for the frequency of KIR region gene carriage observed between-group differences for several telomeric KIR region loci. In a larger set of up to 106 HESN and 439 HIV+ individuals, more HESN than HIV+ subjects were KIR3DS1 homozygotes, lacked a full length KIR2DS4 gene and carried the telomeric group B KIR haplotype motif, TB01. TB01 is characterized by the presence of KIR3DS1, KIR2DL5A, KIR2DS3/5 and KIR2DS1, in linkage disequilibrium with each other. We assessed which of the TB01 encoded KIR gene products contributed to NK cell responsiveness by stimulating NK cells from 8 HIV seronegative KIR3DS1 and TB01 motif homozygotes with 721.221 HLA null cells and evaluating the frequency of KIR3DS1+/-KIR2DL5+/-, KIR3DS1+/-KIR2DS1+/-, KIR3DS1+/-KIR2DS5+/- NK cells secreting IFN-γ and/or expressing CD107a. A higher frequency of NK cells expressing, versus not, KIR3DS1 responded to 721.221 stimulation. KIR2DL5A+, KIR2DS1+ and KIR2DS5+ NK cells did not contribute to 721.221 responses or modulate those by KIR3DS1+ NK cells. Thus, of the TB01 KIR gene products, only KIR3DS1 conferred responsiveness to HLA-null stimulation, demonstrating its ligation can activate ex vivo NK cells.

Indexed as

HIV SeronegativityLymphocyte ActivationCells, CulturedCoculture TechniquesGene FrequencyGenetic LoadHaplotypesHIV InfectionsHLA AntigensHumansKiller Cells, NaturalLinkage DisequilibriumProspective StudiesReceptors, KIRReceptors, KIR2DL5Receptors, KIR3DS1HLA AntigensKIR2DS1 protein, humanKIR2DS5 protein, humanReceptors, KIRReceptors, KIR2DL5Receptors, KIR3DS1

Identifiers

PMID28938026
PMCPMC5609756
OpenAlexW2759957374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.